©The Author(s) 2025.
World J Gastroenterol. Dec 14, 2025; 31(46): 114415
Published online Dec 14, 2025. doi: 10.3748/wjg.v31.i46.114415
Published online Dec 14, 2025. doi: 10.3748/wjg.v31.i46.114415
Figure 3 Organoid-based clinical trials for liver diseases.
A: The categories of the registered liver organoid-based clinical trials according to ClinicalTrial.gov; B and C: The status and location of the abovementioned liver organoid-based clinical trials; D: The distribution of the organoid-based clinical trials for liver diseases according to clinical trial number [condition (N11)] and the corresponding enrolled participants [enrollment (Log10N12)]. HCC: Hepatocellular carcinoma; NASH: Non-alcoholic steatohepatitis.
- Citation: Wang YX, Ren YN, Zhang SS, Sun S, Xu MY, Wei T, Zhang LS. Application of stem cells in the precise diagnosis and treatment of liver diseases. World J Gastroenterol 2025; 31(46): 114415
- URL: https://www.wjgnet.com/1007-9327/full/v31/i46/114415.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i46.114415